22246-71-5

Usage

Uses

Used in Pharmaceutical Industry:
8-Methoxy-2,3,4,5-tetrahydrobenzo[c]azepin-1-one is used as a chemical intermediate for the synthesis of various drugs and bioactive compounds, leveraging its potential to exhibit antipsychotic, anticonvulsant, and sedative properties. This makes it a valuable asset in the development of new medications aimed at treating a spectrum of health conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 8-Methoxy-2,3,4,5-tetrahydrobenzo[c]azepin-1-one is employed as a research compound to explore its pharmacological activities and potential applications in the treatment of neurological disorders and mental health conditions. Its study contributes to the advancement of knowledge regarding its therapeutic scope and the discovery of novel therapeutic agents.

InChI:InChI=1/C11H13NO2/c1-14-9-5-4-8-3-2-6-12-11(13)10(8)7-9/h4-5,7H,2-3,6H2,1H3,(H,12,13)

Upstream product

• 6836-19-7 7-Methoxy-1-tetralone 
• 20175-97-7 7-methoxy-3,4-dihydronaphthalen-1(2H)-one oxime 

Downstream Products

• 247133-22-8 8-Methoxy-2,3,4,5-tetrahydro-1H-benz[c]azepine 
• 247133-24-0 8-hydroxy-2,3,4,5-tetrahydro-1H-benz[c]azepine-2-carboxylic acid tert-butyl ester 
• 374813-35-1 2,3,4,5-tetrahydro-1H-2-benzazepin-8-ol hydrobromide 

Relevant academic research and scientific papers

Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists

We describe the discovery of small molecule benzazepine derivatives as agonists of human peroxisome proliferator-activated receptor δ (PPARδ) that displayed excellent selectivity over the PPARα and PPARγ subtypes. Compound 8 displayed good PK in the rat a

The application of the schmidt reaction and beckmann rearrangement to the synthesis of bicyclic lactams: Some mechanistic considerations

The syntheses of some methoxy-substituted bicyclic lactams, of the types 3 and 4, are reported employing two different conditions for the Schmidt reaction of appropriate ketones and employing two different conditions for the Beckmann rearrangement of the corresponding ketoximes. The alkyl to aryl migration ratios of the reactions were determined by high-performance liquid chromatography analysis of the reactions. The mechanisms of the reactions reported are discussed, some limitations of the reported mechanisms identified, and an alternative mechanism proposed in light of the outcomes of the various reactions. Application of the Schmidt reaction and Beckmann rearrangement was used for the synthesis of some chloro bicyclic lactams, of the types 3 and 4. CSIRO 2010.

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

Compounds of Formula (I) are HIV reverse transcriptase inhibitors, wherein X, R1, R2, R3, R4 and R5 are defined herein. The compounds of Formula (I) and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring

A series of novel 2,7-disubstituted tetrahydroisoquinoline derivatives were designed and synthesized. Among these derivatives, compounds 1 and 2 exhibited potent inhibitory activity against factor Xa (FXa) and good selectivity with respect to other serine

Amidine compounds

A compound of the formula [I] wherein R1, R2and R3are the same or different and each is hydrogen atom, wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof. The compound of the presen

Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III receptor

A benzodiazepinedione derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPIIb IIIa receptor and is provided in therapeutic compositions for t